GKOS
Price
$151.16
Change
-$1.51 (-0.99%)
Updated
Dec 27 closing price
51 days until earnings call
KIDS
Price
$22.89
Change
-$0.49 (-2.10%)
Updated
Dec 27 closing price
65 days until earnings call
Ad is loading...

GKOS vs KIDS

Header iconGKOS vs KIDS Comparison
Open Charts GKOS vs KIDSBanner chart's image
Glaukos
Price$151.16
Change-$1.51 (-0.99%)
Volume$537.87K
CapitalizationN/A
OrthoPediatrics
Price$22.89
Change-$0.49 (-2.10%)
Volume$289.18K
CapitalizationN/A
GKOS vs KIDS Comparison Chart
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. KIDS commentary
Dec 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a StrongBuy and KIDS is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 30, 2024
Stock price -- (GKOS: $151.16 vs. KIDS: $22.89)
Brand notoriety: GKOS and KIDS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GKOS: 93% vs. KIDS: 132%
Market capitalization -- GKOS: $4.61B vs. KIDS: $686.7M
GKOS [@Medical Specialties] is valued at $4.61B. KIDS’s [@Medical Specialties] market capitalization is $686.7M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 1 FA rating(s) are green whileKIDS’s FA Score has 1 green FA rating(s).

  • GKOS’s FA Score: 1 green, 4 red.
  • KIDS’s FA Score: 1 green, 4 red.
According to our system of comparison, GKOS is a better buy in the long-term than KIDS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 4 TA indicator(s) are bullish while KIDS’s TA Score has 3 bullish TA indicator(s).

  • GKOS’s TA Score: 4 bullish, 3 bearish.
  • KIDS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than KIDS.

Price Growth

GKOS (@Medical Specialties) experienced а +0.19% price change this week, while KIDS (@Medical Specialties) price change was +2.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.80%. For the same industry, the average monthly price growth was -2.40%, and the average quarterly price growth was +2.66%.

Reported Earning Dates

GKOS is expected to report earnings on Feb 19, 2025.

KIDS is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Medical Specialties (+0.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than KIDS($687M). GKOS YTD gains are higher at: 90.162 vs. KIDS (-29.591). KIDS has higher annual earnings (EBITDA): -8.38M vs. GKOS (-82.12M). GKOS has more cash in the bank: 295M vs. KIDS (80.3M). KIDS has less debt than GKOS: KIDS (10.1M) vs GKOS (384M). GKOS has higher revenues than KIDS: GKOS (315M) vs KIDS (149M).
GKOSKIDSGKOS / KIDS
Capitalization4.61B687M670%
EBITDA-82.12M-8.38M980%
Gain YTD90.162-29.591-305%
P/E RatioN/A232.56-
Revenue315M149M211%
Total Cash295M80.3M367%
Total Debt384M10.1M3,802%
FUNDAMENTALS RATINGS
GKOS vs KIDS: Fundamental Ratings
GKOS
KIDS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
21100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
3981
P/E GROWTH RATING
1..100
665
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KIDS's Valuation (89) in the Medical Specialties industry is in the same range as GKOS (93). This means that KIDS’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (21) in the Medical Specialties industry is significantly better than the same rating for KIDS (100). This means that GKOS’s stock grew significantly faster than KIDS’s over the last 12 months.

KIDS's SMR Rating (92) in the Medical Specialties industry is in the same range as GKOS (95). This means that KIDS’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Price Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for KIDS (81). This means that GKOS’s stock grew somewhat faster than KIDS’s over the last 12 months.

KIDS's P/E Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for GKOS (66). This means that KIDS’s stock grew somewhat faster than GKOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSKIDS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 14 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
67%
Bearish Trend 26 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIEZX10.81-0.01
-0.09%
Destinations International Equity Z
INIVX10.49-0.03
-0.29%
VanEck International Investors Gold A
OGLNX92.30-0.77
-0.83%
Invesco Global R
RYAWX102.77-1.52
-1.46%
Rydex S&P 500 Pure Growth H
RYCTX268.41-6.12
-2.23%
Rydex S&P 500 2x Strategy C

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with PRCT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then PRCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-0.99%
PRCT - GKOS
44%
Loosely correlated
-1.82%
BLFS - GKOS
42%
Loosely correlated
-1.63%
ICUI - GKOS
40%
Loosely correlated
-1.28%
OFIX - GKOS
40%
Loosely correlated
-1.68%
MMSI - GKOS
40%
Loosely correlated
-1.16%
More

KIDS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KIDS has been loosely correlated with LUNG. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KIDS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KIDS
1D Price
Change %
KIDS100%
-2.10%
LUNG - KIDS
43%
Loosely correlated
-2.62%
FNA - KIDS
43%
Loosely correlated
-1.55%
AORT - KIDS
41%
Loosely correlated
-1.16%
HBIO - KIDS
41%
Loosely correlated
-5.71%
XRAY - KIDS
41%
Loosely correlated
-0.32%
More